{"product_id":"scripps-11th-annual-structural-heart-intervention-and-imaging-2022","title":"Scripps 11th Annual Structural Heart Intervention and Imaging 2022","description":"\u003ch3\u003eScripps 11th Annual Structural Heart Intervention and Imaging 2022\u003c\/h3\u003e\n\u003ch4\u003e Include: 19 videos + 1 pdf, size: 3.62 GB\u003cbr\u003eTarget Audience: cardiologist, radiologist, sonographer\u003c\/h4\u003e\n\u003ch3\u003eCourse Overview\u003c\/h3\u003e\u003cbr\u003eScripps 11th Annual Structural Heart Intervention and Imaging 2022 Scripps’ Structural Heart Intervention and Imaging conference is designed to provide a practical, cutting-edge, and live case-based assessment of the emerging area of structural heart disease interventions and cardiovascular imaging. The course will place a strong emphasis on the collaborative nature of these procedures across many disciplines within cardiology. Expert faculty will include interventionists, invasive cardiologists, echocardiologists, electrophysiologists, cardiothoracic surgeons, cardiac anesthesiologists, and sonographers. Faculty\u003cbr\u003ewill discuss clinical guidelines on patient selection, pre-procedural assessment, procedural tips, techniques, and challenges (including concurrent imaging) during the performance of the procedures and conclude with assessment of outcomes and future directions.\u003cbr\u003e\u003cbr\u003eConference Highlights\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMultidisciplinary expert faculty emphasizing a team approach to care\u003c\/li\u003e\n\u003cli\u003eBased structural heart disease interventional procedures with intraprocedural imaging, clinical-pathological correlations with ex vivo cardiac specimen, and pertinent didactic lectures\u003c\/li\u003e\n\u003cli\u003eInteractive formats, panel discussions, Q\u0026amp;A, and more\u003c\/li\u003e\n\u003cli\u003eLive satellite case transmissions\u003c\/li\u003e\n\u003cli\u003eExpanded satellite symposia and hands-on workshops\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eEducational Objectives\u003c\/h4\u003e\n\u003ch5\u003eAfter attending this live activity, participants should be able to:\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eAssemble the appropriate multidisciplinary team, imaging technologies, and catheter equipment to perform structural heart disease interventions.\u003c\/li\u003e\n\u003cli\u003eApply a comprehensive approach to the assessment of the aortic, mitral, and tricuspid valves, the interatrial septum, and the left and right ventricles, using echocardiography (TTE, TEE, and ICE), CT, and MRI for the purpose of the interventional treatment of these cardiac structures.\u003c\/li\u003e\n\u003cli\u003eCite the current indications for LAA closure, PFO closure, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), and mitral transcatheter edge to edge repair (TEER).\u003c\/li\u003e\n\u003cli\u003eInterpret echocardiographic and CT imaging before and after LAA closure, and identify and measure peri-device leaks, device-related thrombus, and other potential complications.\u003c\/li\u003e\n\u003cli\u003eSelect the appropriate treatment strategy for patients with mitral valve disease (i.e., TEER or TMVR) or tricuspid valve disease (i.e., TEER or TTVR) based upon imaging findings.\u003c\/li\u003e\n\u003cli\u003eIncorporate live TEE multiplanar imaging to optimize transcatheter mitral and tricuspid valve intervention.\u003c\/li\u003e\n\u003cli\u003eUtilize 2D and 4D ICE during structural heart intervention.\u003c\/li\u003e\n\u003cli\u003eRecognize the risk of left ventricular outflow tract obstruction after TMVR and coronary occlusion after TAVR and apply specific interventional strategies to prevent them (e.g., LAMPOON and BASILICA).\u003c\/li\u003e\n\u003cli\u003eIntegrate emerging data regarding surgical risk, including low and intermediate-risk patients into TAVR decision-making.\u003c\/li\u003e\n\u003cli\u003eIdentify heart failure patients who might benefit from novel interventional strategies, such as interatrial shunt devices, to improve symptoms.\u003c\/li\u003e\n\u003cli\u003eOptimize the anesthetic management of patients with reduced ejection fraction undergoing TEER or TMVR.\u003c\/li\u003e\n\u003cli\u003eEmploy best practices to safely manage potential complications of catheterbased therapies for structural heart disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eInterventional and Invasive Cardiologists\u003c\/li\u003e\n\u003cli\u003eEchocardiographers\u003c\/li\u003e\n\u003cli\u003eInterventional Radiologists\u003c\/li\u003e\n\u003cli\u003eCardiovascular Surgeons and Anesthesiologists\u003c\/li\u003e\n\u003cli\u003eCardiology Nurses and Nurse Practitioners\u003c\/li\u003e\n\u003cli\u003eCardiovascular Sonographers\u003c\/li\u003e\n\u003cli\u003eCardiac Catheterization Technicians\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003e Topics:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ebrochure_sh22_compressed.pdf\u003c\/li\u003e\n\u003cli\u003eCases of ASD Closure with the Novel Cardioform ASD Occluder- Sizing, Technique, and Advanced Tips –and Tricks-B. Gordon, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCommon Logistical Issues and How to Overcome Them-Kristen Billick, BS, ACS, RDCS.mp4\u003c\/li\u003e\n\u003cli\u003eComplex PFO Closure with the Cardioform Septal Occluder- Case Examples-Joseph Aragon, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHow to Integrate Academics and Research-Michael Picard, MD.mp4\u003c\/li\u003e\n\u003cli\u003eIdentifying Key Personnel to Support a Structural Program-Konstantinos Koulogiannis, MDs.mp4\u003c\/li\u003e\n\u003cli\u003eImaging Pearls for Guiding Mitral TEER My Best Tips and Tricks-Moody Makar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eIntracardiac Echocardiography (ICE) for Transcatheter LAA Occlusion- A Practical Workshop-S. Doshi,MD, M. Price,MD, J. Saw,MD.mp4\u003c\/li\u003e\n\u003cli\u003eKey Design Features and Clinical Data for the Cardioform Septal \u0026amp; Cardioform ASD Occluders- M. Price,MD.mp4\u003c\/li\u003e\n\u003cli\u003eLAAC Case Presentation-Gagan Singh, MD.mp4\u003c\/li\u003e\n\u003cli\u003eLifetime Management of the TAVR Patient and Considerations for Cerebral Protection to Mitigate Stroke-Michael Rinaldi, MD.mp4\u003c\/li\u003e\n\u003cli\u003eMechanism of Action of IVL and Technical Approach-James McCabe, MD.mp4\u003c\/li\u003e\n\u003cli\u003eMitral TEER Challenging Case Examples-Paul Mahoney, MD.mp4\u003c\/li\u003e\n\u003cli\u003eNavigating Equipment and Knobology-Steven Romero, MD.mp4\u003c\/li\u003e\n\u003cli\u003eOptimizing Treatment for Your NVAF Patients Data, Tools, and The Future of LAAC-Jacqueline Saw, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSelecting Alternative or Transfemoral Access My Approach-Curtis Stinis, MD.mp4\u003c\/li\u003e\n\u003cli\u003eStructural Echo Lab Intangibles–Stephen Little, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTEER in 2022 Guideline Updates, Current Clinical Outcomes, Lower-Risk Patients, and Expanding to the Tricuspid-Matthew Price, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTiming of TEER for FMR A Heart Failure Specialist’s Perspective-Ajay Srivastava, MD.mp4\u003c\/li\u003e\n\u003cli\u003eWhen The Going Gets Tough, The Tough Gets Intravascular Lithotripsy Case Examples-Rahul Sharma, MBBS.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954289971298,"sku":"MED-AMB00371","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-11th-Annual-Structural-Heart-Intervention-and-Imaging-2022-1.jpg?v=1779370168","url":"https:\/\/meducourse.com\/products\/scripps-11th-annual-structural-heart-intervention-and-imaging-2022","provider":"Meducourse","version":"1.0","type":"link"}